Company / FCF Margin
Supernus Pharmaceuticals, Inc. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
6.4%
FY2025
5-year range
6.4% / 25.9%
FY2021-FY2025
Trend
-75.3%
vs FY2024
Sector context
#51 of 134
Health Care
What the data says
At 6.4%, Supernus Pharmaceuticals, Inc.'s fcf margin ranks #51 of 134 in the Health Care sector. FCF Margin has fluctuated over the past 9 years, ranging from -27.1% in FY2016 to 164.3% in FY2019.
Based on SEC 10-K filings.
6.4% in FY2025 with a 5-year CAGR of -19.5%.
Declined from 18.2% to 6.4% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -11.0pp
- 5-Year Change
- -19.5pp
- 10-Year Change
- -
Sector benchmark
#51 of 134 in Health CareTop 38% of 134This company 6.4% Sector average -637.8%
▼
+101.0% above sector average
Key checks
Key Insights
- In FY2025, fcf margin decreased 75.3% year-over-year.
- Currently 644.2pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2019.
- Lowest fcf margin in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 6.4% | -75.3% |
| FY2024 | 25.9% | +42.2% |
| FY2023 | 18.2% | +4.2% |
| FY2022 | 17.4% | - |
| FY2021 | - | - |
| FY2020 | 25.9% | -84.2% |
| FY2019 | 164.3% | +441.5% |
| FY2018 | 30.3% | +38.0% |
| FY2017 | 22.0% | +181.2% |
| FY2016 | -27.1% | -223.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026